Learning Objectives:
- Explain the European CE marking approach with respect to medical devices, active implantables and IVDs, including borderlines with other products, as covered by the three Council Directives (MDD, AIMDD, IVDD) and the underlying Commission Directives such as the animal tissue directive and blood derivative directives.
- Explain the significance of the EU risk classification criteria for medical devices in determining the conformity assessment routes and quality assurance requirements for the various risk classes, as well as the routes to compliance for borderline products that include pharmaceuticals, human derivatives and/or engineered tissues.
- Describe the role of the essential requirements as the basis for CE marking, including the use of standards.
- Describe the role of clinical data and risk management.
- Identify the necessary steps required for post market surveillance and for reporting adverse incidents under the vigilance system.
- Identify technical documentation requirements
BSI In-Company (In-House) Training Option gives you:
• Onsite delivery
We come to you: Save money. Avoid travel and accommodation expenses.
• Training designed for you
Based on your needs, we can build the course to help you achieve your specific objectives.
• More for less
Include team members cost-effectively with BSI In-Company training.
Contact us for a customised quote today.
Further Information
There is no prerequisite from this course but participants will benefit from a basic knowledge of medical device use or manufacture.
Delegates will earn 16 CPD points
Next Steps

Download our healthcare training brochure
Book Now or
Request a Quote or
Contact us:
+44 (0)845 086 9000
training@bsigroup.com